Safety

News

scientifically visualization of a coronavirus spike protein

AZ, J&J tweaking COVID shots to reduce clotting risks; repor...

AstraZeneca and Johnson & Johnson are both exploring ways to modify their COVID-19 vaccines to minimise the risk of severe blood clotting reactions that are seen – albeit rarely – in so

News

FDA adds warning of rare neurological side effect to J&J COV...

The FDA has added a new warning on the Johnson & Johnson COVID-19 vaccine, saying the shot has been linked to a serious but rare side effect – Guillain-Barré syndrome – that can cause m

News

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

Study links AstraZeneca COVID-19 shot to bleeding disorder I...

Researchers in Scotland have identified a possible link between the Oxford University/AstraZeneca COVID-19 and a mostly mild and generally treatable bleeding disorder.

News

Novartis halts three trials of Beovu eye drug on safety conc...

Prospects for Novartis' ophthalmology drug Beovu have taken another dive after the drugmaker reported toxicity issues in a new phase 3 trial in wet age-related macular degeneration (AMD).

News

Belgium halts dosing of J&J COVID vaccine in under 41s after...

Belgium's Ministry of Health has paused dosing of people under the age of 41 with Johnson & Johnson's one-shot COVID-19 vaccine, following the death of a woman from what appeared to be

News

Safety of mRNA COVID-19 jabs backed, despite myocarditis cas...

As US and EU health regulators review cases of heart inflammation seen in young people administered mRNA-based COVID-19 vaccines from Pfizer/BioNTech and Moderna, cardiologists have come ou

AZ, J&J tweaking COVID shots to reduce clotting risks; repor...

FDA adds warning of rare neurological side effect to J&J COV...

Study links AstraZeneca COVID-19 shot to bleeding disorder I...

Novartis halts three trials of Beovu eye drug on safety conc...

Belgium halts dosing of J&J COVID vaccine in under 41s after...

Safety of mRNA COVID-19 jabs backed, despite myocarditis cas...

Threat of Trump's pharma tariffs looms again

Using AI-driven synthetic personas to take your insights fur...

Safety

Editor's Picks